Literature DB >> 17880024

Health service delivery in China: a literature review.

Karen Eggleston1, Li Ling, Meng Qingyue, Magnus Lindelow, Adam Wagstaff.   

Abstract

We report the results of a review of the Chinese- and English-language literatures on service delivery in China, asking how well China's health-care providers perform and what determines their performance. Although data and methodological limitations suggest caution in drawing conclusions, a critical reading of the available evidence suggests that current health service delivery in China leaves room for improvement, in terms of quality, responsiveness to patients, efficiency, cost escalation, and equity. The literature suggests that these problems will not be solved by simply shifting ownership to the private sector or by simply encouraging providers -- public and private -- to compete with one another for individual patients. By contrast, substantial improvements could be (and in some places have already been) made by changing the way providers are paid -- shifting away from fee-for-service and the distorted price schedule. Other elements of 'active purchasing' by insurers could further improve outcomes. Rigorous evaluations, based on richer micro-level data, could considerably strengthen the evidence base for service delivery policy in China.

Entities:  

Mesh:

Year:  2008        PMID: 17880024     DOI: 10.1002/hec.1306

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  100 in total

1.  Soft budget constraints in China: evidence from the Guangdong hospital industry.

Authors:  Karen Eggleston; Yu-Chu Shen; Mingshan Lu; Congdong Li; Jian Wang; Zhe Yang; Jing Zhang
Journal:  Int J Health Care Finance Econ       Date:  2009-04-28

2.  Measuring attitude toward social health insurance.

Authors:  Chung-Ping A Loh; Katrin Nihalani; Oliver Schnusenberg
Journal:  Eur J Health Econ       Date:  2011-06-01

3.  Giving birth at a health-care facility in rural China: is it affordable for the poor?

Authors:  Qian Long; Yaoguang Zhang; Joanna Raven; Zhuochun Wu; Lennart Bogg; Shenglan Tang; Elina Hemminki
Journal:  Bull World Health Organ       Date:  2010-12-02       Impact factor: 9.408

4.  Primary care reform in China.

Authors:  Yu Wang; Martin Wilkinson; Edward Ng; K K Cheng
Journal:  Br J Gen Pract       Date:  2012-10       Impact factor: 5.386

5.  Effects of China's national essential medicines policy on the use of injection in primary health facilities.

Authors:  Xiaoxi Xiang; Chunyan Yang; Difei Wang; Jing Ye; Xinping Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

6.  The impact of health insurance on health outcomes and spending of the elderly: evidence from China's New Cooperative Medical Scheme.

Authors:  Lingguo Cheng; Hong Liu; Ye Zhang; Ke Shen; Yi Zeng
Journal:  Health Econ       Date:  2014-04-29       Impact factor: 3.046

7.  Effects of Integrated Case Payment on Medical Expenditure and Readmission of Inpatients with Chronic Obstructive Pulmonary Disease: A Nonrandomized, Comparative Study in Xi County, China.

Authors:  Meng Shi; Jing Wang; Liang Zhang; Yan Yan; Yu-Dong Miao; Xiang Zhang
Journal:  Curr Med Sci       Date:  2018-06-22

8.  Comparing public and private hospitals in China: evidence from Guangdong.

Authors:  Karen Eggleston; Mingshan Lu; Congdong Li; Jian Wang; Zhe Yang; Jing Zhang; Hude Quan
Journal:  BMC Health Serv Res       Date:  2010-03-23       Impact factor: 2.655

9.  Utilisation, contents and costs of prenatal care under a rural health insurance (New Co-operative Medical System) in rural China: lessons from implementation.

Authors:  Qian Long; Tuohong Zhang; Elina Hemminki; Xiaojun Tang; Kun Huang; Shengbin Xiao; Rachel Tolhurst
Journal:  BMC Health Serv Res       Date:  2010-11-01       Impact factor: 2.655

10.  Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.

Authors:  Wen Chen; Shenglan Tang; Jing Sun; Dennis Ross-Degnan; Anita K Wagner
Journal:  BMC Health Serv Res       Date:  2010-07-17       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.